1-5 of 5
Michelle Rudek
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Brentuximab Vedotin in Combination with AVD in Stage II-IV HIV-Associated Classical Hodgkin Lymphoma: Results of the Phase 2 Study, AMC 085

Paul G. Rubinstein, MD, Page C. Moore, PhD, Milan Bimali, PhD, Amy Chadburn, MD, Ethel Cesarman, MD PhD, Michelle Rudek, PharmD, PhD, Lee Ratner, MD PhD, Richard F. Ambinder, MD, David H. Henry, MD, Stefan K. Barta, MD MRCP, MS, Herve Ghesquieres, MD PhD, Paul Coppo, MD PhD, Pierre Delobel, MD, Francois Boue, MD PhD, Lionel Galicier, MD, Juan Carlos Ramos, MD BS, Erin G. Reid, MD MS, Elad Sharon, MD MPH, Nicolas Mounier, MD, Caroline Besson, MD PhD, Ariela Noy, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 130.
https://doi.org/10.1182/blood-2019-126787
Published: 2019
Journal Articles

A Phase Ib/II Study of the Histone Methyltransferase Inhibitor Pinometostat in Combination with Azacitidine in Patients with 11q23-Rearranged Acute Myeloid Leukemia

Kamal Menghrajani, MD, Sheng F Cai, MD PhD, Sean M. Devlin, PhD, Scott A. Armstrong, MD PhD, Richard Piekarz, MD PhD MS, BA, Michelle Rudek, PharmD, PhD, Martin S. Tallman, MD, Eytan M. Stein, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2655.
https://doi.org/10.1182/blood-2019-121926
Published: 2019
Journal Articles

TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo

Hayley Ma, Bao Nguyen, Li Li, Sarah Greenblatt, Allen Williams, Ming Zhao, Mark Levis, Michelle Rudek, Amy Duffield, Donald Small
Journal: Blood
Blood (2014) 123 (10): 1525–1534.
https://doi.org/10.1182/blood-2013-08-523035
Published: 2014
Includes: Supplemental data
Journal Articles

Phase I Trial of the Oral Poly (ADP-ribose) Polymerase (PARP) Inhibitor Veliparib (ABT-888, V) Combined Wtih Topoecan (T) and Carboplatin (C) for Adults with Relapsed and Refractory Acute Leukemias

Judith E. Karp, MD, Keith W Pratz, MD, Mark R. Litzow, MD, Jiuping Ji, PhD, Alice Chen, MD, Michelle Rudek, PharmD, PhD, Scott H. Kaufmann, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3276.
https://doi.org/10.1182/blood.V116.21.3276.3276
Published: 2010
Journal Articles

Flavopiridol Down-Regulates Genes Involved in Cell Cycle Regulation and Tumor Progression in Adults with Refractory or Poor-Risk Acute Leukemia.

Linda Resar, M.D., Joelle Hillion, Ph.D., Katrina Alino, R.N., B.S.N., Michelle Rudek, Pharm.D., Ph.D., Judith Karp, M.D.
Journal: Blood
Blood (2008) 112 (11): 953.
https://doi.org/10.1182/blood.V112.11.953.953
Published: 2008